NEW
YORK, July 10, 2024 /PRNewswire/ -- The global
fertility services market size is estimated to grow by
USD 8.16 billion from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of almost 7.18% during the forecast period. The
global fertility services market is poised to grow significantly,
driven by factors such as increasing prevalence of late parenthood.
However, challenges persist, notably high complication rates
associated with fertility treatments. These complexities hinder
market expansion despite technological advancements. Key players
like Anecova SA, Apollo Hospitals Enterprise Ltd., and others are
crucial in navigating these challenges, ensuring the delivery of
effective fertility solutions amidst rising cases of conditions
like prostate cancer, which also impact fertility trends.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Service (Treatment
services, Testing and storage services, and Others), End-user
(Fertility clinics, Hospitals, Surgical centers, and Clinical
research institutes), and Geography (North America, Europe, APAC,
Middle East and Africa, and South America)
|
Region
Covered
|
North America, Europe,
APAC, Middle East and Africa, and South America
|
Key companies
profiled
|
Anecova SA, Apollo
Hospitals Enterprise Ltd, CARE Fertility Group Ltd., Carolinas
Fertility Institute, Cryolab Ltd., Genea Ltd., Instituto Bernabeu
SL, Instituto Valenciano de Infertilidad, Kids Clinic India Pvt.
Ltd., Lucile Packard Childrens Hospital, Medicover AB, Merck KGaA,
Monash IVF Group Ltd., Nova IVF Fertility Private Ltd, The Cooper
Companies Inc., The Johns Hopkins Health System Corp., University
of Pennsylvania Health System, Virtus Health, Vitrolife AB, and
Xytex Corp.
|
Key Market Trends Fueling Growth
The global increase in prostate cancer cases, a common form of
cancer among men, results in a significant number of men undergoing
prostatectomy or radiation therapy, which often impairs their
fertility. During these treatments, the prostate gland and seminal
vesicles, structures responsible for producing semen, are removed
or damaged. Consequently, men are unable to ejaculate and fertilize
an egg, leading to a demand for fertility services such as
artificial insemination and IVF using stored semen. The market for
these services will expand due to the rising cases of prostate
cancer and medical recommendations.
The Fertility Services market is experiencing significant growth
due to various trends. The LGBT community and career-oriented
individuals are seeking family planning solutions. Delayed
pregnancies, academic and career ambitions, financial stability,
and excessive workloads are driving demand. Sedentary lifestyle
habits, smoking, drug consumption, medical ailments, and
infertility-causing medical illnesses like Endometrial tuberculosis
are contributing factors. Advertising and promotion through
televisions and online portals reach disposable income consumers.
Services include Intrauterine Insemination (IUI) using Fresh
Non-Donor, Frozen Non-Donor, Fresh Donor, and Frozen Donor sperm.
Surgical Centers and Cryobanks offer advanced treatments like ICSI,
focusing on sperm morphology, motility, and count. Fertility
clinics employ human-centered care (HCC) using AI and robots
(robotics) to enhance efficiency. Oma Fertility and embryologists
provide expert care, addressing infertility causes and improving
success rates.
Discover 360° analysis of this market. For complete information,
schedule your consultation- Book Here!
Market Challenges
- Fertility services involve various treatments, including
artificial insemination and medications, which carry potential
risks and complications. Women undergoing these treatments may
experience multiple pregnancies, ovarian hyperstimulation syndrome,
internal bleeding or infection, premature delivery, low-weight
babies, and congenital defects. Medications used for infertility
can lead to side effects such as depression, miscarriage, premature
delivery, abdominal pain, and mood swings. Complications for male
fertility services are less common but can include infections,
bruising, bleeding, and limited efficacy. Allergic reactions to
anesthesia are also possible. Antibiotics and gonadotropins can
cause diarrhea and hot flashes, breast tenderness, swelling,
abdominal pain, bloating, and menopause-type symptoms,
respectively. These complications and side effects can deter
individuals from seeking fertility services due to concerns over
personal health and future outcomes. Prospective clients carefully
consider success rates and the reputations of healthcare facilities
before making a decision. To grow the fertility services market, it
is essential to minimize these risks and provide transparent
information to potential clients.
- The Fertility Services Market faces several challenges that
impact the growth and accessibility of infertility treatments. One
significant challenge is the rising trend of Medical Tourism,
leading to increased competition from low-cost fertility clinics
and hospitals in other countries. Another challenge is the impact
of Lifestyle alterations such as Obesity, Stress, Depression, and
Alcohol use on fertility. Male infertility, often caused by Low
sperm count or Hormonal imbalance, and Female infertility,
resulting from issues with the Hypothalamus, Pituitary gland, or
Ovaries, require various procedures like Hysteroscopy, Laparoscopy,
IUI, IVF, and Infertility drugs. Infertile Couples and Single
Parents face financial burdens due to the high cost of treatments
like In-Vitro Fertilization, Artificial Insemination, Surrogacy,
Donor, and Non-donor options. The use of Fertility Clinics,
Hospitals, Clinical Research Institutes, and Surgical Centers for
these services further adds to the expenses. Moreover, the
regulatory landscape, such as the National Provider Reimbursement
(NPR), affects the affordability and accessibility of these
services. The market also faces challenges in addressing the stigma
surrounding infertility and increasing awareness about the various
Fertility Services and Procedures available.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This fertility services market report extensively covers market
segmentation by
- Service
- 1.1 Treatment services
- 1.2 Testing and storage services
- 1.3 Others
- End-user
- 2.1 Fertility clinics
- 2.2 Hospitals
- 2.3 Surgical centers
- 2.4 Clinical research institutes
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 APAC
- 3.4 Middle East and
Africa
- 3.5 South America
1.1 Treatment services- The Fertility Services
Market is primarily driven by the Treatment Services segment due to
the high cost of these services and the prevalence of conditions
like diabetes and obesity that impact reproductive health. In the
US, approximately 1.7% of infants are conceived using ART
procedures, which have seen increasing success and adoption.
Factors such as late parenthood, awareness, and innovation in ART
procedures are fueling market growth. However, affordability
remains a challenge in rural areas. Initiatives to increase access,
education, and income levels are expected to boost demand for
treatment services and drive the global Fertility Services
Market.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Research Analysis
The Fertility Services market encompasses a range of healthcare
facilities and specialized clinics that offer treatments for
infertility. Infertility is a growing health concern affecting
millions of couples worldwide, with both males and females
experiencing various issues such as low sperm count, hormonal
imbalance, and structural problems. Fertility clinics, hospitals,
clinical research institutes, and surgical centers provide various
fertility procedures like In-Vitro Fertilization (IVF), Artificial
Insemination (AI), Surrogacy, and donor or non-donor options.
Fertility services also address infertility-causing medical
illnesses, including Endometrial tuberculosis. Sperm morphology,
motility, and count are crucial factors assessed during fertility
evaluations. ICSI (Intracytoplasmic Sperm Injection) is a common
assisted reproductive technology used to overcome male infertility
issues. Fertility services aim to help couples achieve pregnancy
and parenthood despite these challenges.
Market Research Overview
The Fertility Services market encompasses a range of healthcare
facilities and specialized clinics that offer various infertility
treatments. These services include Intracytoplasmic Sperm Injection
(ICSI), In Vitro Fertilization (IVF), and Artificial Insemination
(IUI), among others. Fertility clinics utilize advanced
technologies such as AI and robots (robotics) to enhance the
effectiveness of these procedures. Sperm count, motility, and
morphology are crucial factors in assessing male fertility, while
infertility-causing medical illnesses, such as Endometrial
tuberculosis, also play a significant role. Embryologists oversee
the complex processes, and services like hysteroscopy, laparoscopy,
and egg-freezing are also offered. Factors contributing to
infertility include lifestyle alterations, obesity, stress,
depression, alcohol use, and hormonal imbalances in both males and
females. Infertile couples, single parents, the LGBT community, and
career-oriented individuals seek fertility services, driven by
family planning, academic ambitions, career ambitions, financial
stability, and delayed pregnancies. Advertising and promotion
through various media channels, including televisions and online
portals, target disposable incomes to attract potential clients.
Infertility drugs and medications are essential components of these
treatments, and the market continues to evolve with ongoing
clinical research institutes and surgical centers.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Service
-
- Treatment Services
- Testing And Storage Services
- Others
- End-user
-
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- Geography
-
- North America
- Europe
- APAC
- Middle East And Africa
- South America
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fertility-services-market-size-is-set-to-grow-by-usd-8-16-billion-from-2024-2028--rising-prevalence-of-late-parenthood-to-boost-the-market-growth-technavio-302192939.html
SOURCE Technavio